PAA 2.33% 21.0¢ pharmaust limited

Hi Jockthegreat,The average ALSFRS score on MND diagnosis is...

  1. 1,043 Posts.
    lightbulb Created with Sketch. 1978
    Hi Jockthegreat,

    The average ALSFRS score on MND diagnosis is 38.7 +/- 5.64.

    Our longest patient on the MND trial post diagnosis is 48 months.

    Relyvrio reduces the ALSFRS by minus 1.24 per month.

    The average longevity for a patient on a minus 0.6 score per month is 46.5 months. So that's nigh on 4 years

    The autophagy Monepantel affect is cumulative over time.

    MT was chatting about it from the 31 minute mark about the proposed ALSFRS scores here.


    A one point drop on the ALSFRS score equals an increased mortality of 7%.

    The ALSFRS score is not linear. So if Monepantel drops the score to a minus 0.6 units per month it doesn't mean the mortality rate is 4%.

    They will be using Bayesian statistics to get a probability distribution of the mortality rate v ALSFRS so I come up with the figure of 6 years

    Its the best I can calculate.

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950444/

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987707/


    Kpax










 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
21.0¢
Change
-0.005(2.33%)
Mkt cap ! $83.14M
Open High Low Value Volume
21.5¢ 21.5¢ 21.0¢ $76.40K 362.7K

Buyers (Bids)

No. Vol. Price($)
6 68378 20.5¢
 

Sellers (Offers)

Price($) Vol. No.
21.0¢ 17640 2
View Market Depth
Last trade - 11.41am 04/06/2024 (20 minute delay) ?
Last
20.5¢
  Change
-0.005 ( 4.21 %)
Open High Low Volume
21.0¢ 21.5¢ 20.5¢ 273860
Last updated 11.50am 04/06/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.